Experience

Perha Pharmaceuticals

• France
• Biotechnology Research
• 1 - 100 Employee

• Scientific Researcher

  • Jul 2019 - Present

  Development of DYRK1A inhibitors for Down Syndrome and Alzheimer's disease Development of DYRK1A inhibitors for Down Syndrome and Alzheimer's disease



ManRos Therapeutics

• France
• Biotechnology Research
• 1 - 100 Employee

• Scientifc researcher

  • Sep 2017 - Jun 2019

  Development of DYRK1A inhibitors for Down Syndrome and Alzheimer's disease Development of DYRK1A inhibitors for Down Syndrome and Alzheimer's disease



Sahlgrenska Cancer Cente

• Göteborg, Suède

• Postdoctoral fellow

  • Sep 2015 - Aug 2017

  Evaluation of individually designed targeted therapies against melanoma using patient-derived xenograft (PDX) mouse models and development of a mouse model of adoptive cell therapy Evaluation of individually designed targeted therapies against melanoma using patient-derived xenograft (PDX) mouse models and development of a mouse model of adoptive cell therapy



CRBM - CNRS UMR5237

• France
• Research Services
• 1 - 100 Employee

• Postdoctoral fellow

  • Jun 2013 - Jul 2015

  Design and evaluation of peptide-based nanoparticles (cell penetrating peptides) for in vitro and in vivo delivery of siRNAs Design and evaluation of peptide-based nanoparticles (cell penetrating peptides) for in vitro and in vivo delivery of siRNAs



Inserm U1078

• PhD

  • Nov 2012 - Dec 2012

• PhD Student

  • Oct 2009 - Nov 2012

  Development, formulation and biodistribution of synthetic gene delivery systems for the treatment of cystic fibrosis